Validation of stem cell markers in clinical prostate cancer: α6-integrin is predictive for non-aggressive disease.
about
Current Stem Cell Biomarkers and Their Functional Mechanisms in Prostate CancerTension in CancermPGES-1 in prostate cancer controls stemness and amplifies epidermal growth factor receptor-driven oncogenicity.Gene-expression analysis of gleason grade 3 tumor glands embedded in low- and high-risk prostate cancer.BMI-1 Targeting Interferes with Patient-Derived Tumor-Initiating Cell Survival and Tumor Growth in Prostate Cancer.Coalition of Oct4A and β1 integrins in facilitating metastasis in ovarian cancer.The Presence of EpCAM(-)/CD49f(+) Cells in Breast Cancer Is Associated with a Poor Clinical OutcomeTie-2 regulates the stemness and metastatic properties of prostate cancer cells.Prognostic histopathological and molecular markers on prostate cancer needle-biopsies: a reviewIntegrins and cancer: regulators of cancer stemness, metastasis, and drug resistance.The Cohesive Metastasis Phenotype in Human Prostate Cancer.Prostate Cancer Stem Cell Markers Drive Progression, Therapeutic Resistance, and Bone Metastasis.Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors that Can Function as a Cell of Origin for Prostate Cancer.
P2860
Q26742062-71ED77EB-A46F-49DF-A5ED-8542DACF9DECQ28066437-62469E0E-6849-4CA6-9E3D-164E467535FFQ35921941-196373D7-7A70-427F-B9B4-35B8D49AF212Q36021088-24450B41-7915-46F1-8970-E3E196ED0046Q36053741-213F94E3-EA49-4380-8774-73BC7D661C9CQ36070842-06C12968-ACFD-41A0-9DFB-ED36CA8AD07EQ36145709-DA96EEAB-74A7-4CAA-AAAC-855D3E35C1FFQ36771868-C77D2DCB-2238-4F6C-8564-0F1C0F8761CBQ38253055-F47C9A13-BED1-4916-94F7-E7FF085AA356Q38311815-2C78A088-8A24-4708-8328-86A5730BAE73Q38966462-C42DCFBF-E0A7-4E19-9B90-22DE3E7663BEQ39424549-4C37957B-CD41-47C2-B0CC-ADEAF2805118Q42247800-0FFEC482-B2FD-443F-B7E8-1EE2B879BECC
P2860
Validation of stem cell markers in clinical prostate cancer: α6-integrin is predictive for non-aggressive disease.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Validation of stem cell marker ...... ve for non-aggressive disease.
@en
Validation of stem cell marker ...... ve for non-aggressive disease.
@nl
type
label
Validation of stem cell marker ...... ve for non-aggressive disease.
@en
Validation of stem cell marker ...... ve for non-aggressive disease.
@nl
prefLabel
Validation of stem cell marker ...... ve for non-aggressive disease.
@en
Validation of stem cell marker ...... ve for non-aggressive disease.
@nl
P2093
P2860
P50
P356
P1433
P1476
Validation of stem cell marker ...... ive for non-aggressive disease
@en
P2093
A Marije Hoogland
Fritz H Schröder
Geert J L H van Leenders
Guido Jenster
Mark F Wildhagen
P2860
P304
P356
10.1002/PROS.22768
P577
2013-12-27T00:00:00Z